2m 2m 2m 2m 2m 2m 2m
CENTURY THERAP (IPSC)
NASDAQ
$1.58-$0.04 (-2.17%)
Price as of Oct 02, 2026 6:36 PM EDT- $291.5MMarket Cap
- 223.55%1-Year Change
- BiotechnologyIndustry
CENTURY THERAP (IPSC)
$1.58-$0.04 (-2.17%)
IPSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.61 | ||
Change | -$0.10 (-5.85%) | ||
Open | $1.65 | ||
High | $1.70 | ||
Low | $1.59 | ||
Previous Close | $1.71 | ||
Volume | 622,505 | ||
30-Day Average Volume | 490,649 | ||
1-Week Change | -4.73% | ||
1-Month Change | -20.69% | ||
1-Year Change | 223.55% | ||
3-Year Change | -19.50% | ||
5-Year Change | -93.00% | ||
Fundamentals | |||
Shares Outstanding | 181.1M | ||
Total Assets | $287.0M | ||
Market Cap | $291.5M | ||
Enterprise Value | $241.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.5M | ||
Free Cash Flow | -$20.5M | ||
EBIT | -$34.5M | ||
EBITDA | -$31.9M | ||
Net Working Capital | $109.7M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue